NXTC vs WST · $11.5M cap vs P/E 35, rev $1.72B
NextCure Inc (NXTC) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
NextCure Inc (NXTC) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
NXTC does not have a complete income-statement cache yet.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NXTC currently screens at market cap $11.5M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NXTC and WST stock pages for the full models.
Not investment advice.